ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,374.00
-0.06%
S&P ASX All Technology
3,953.80
1.34%
Brent Oil
75.135
-0.30%
US Dollar vs AUD
1.61346
0.32%
Bitcoin
99,249.04
-2.14%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Newron Pharmaceuticals Spa. (NP5) Share Price

Newron Pharmaceuticals Spa.

Newron Pharmaceuticals Spa. (NP5)

TG
9.99
0.03
( 0.30% )
Updated: 18:21:46
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
9.99
Bid
9.96
Offer
10.00
Volume
11
9.99 Day's Range 9.99
6.65 52 Week Range 13.50
Market Cap
178.275M
Previous Close
9.96
Open
9.99
Last Trade
11
@
9.99
Last Trade Time
18:05:21
Financial Volume
-
VWAP
-
Average Volume (3m)
8,823
Shares Outstanding
17,845,345
Dividend Yield
-
PE Ratio
-10.30
Earnings Per Share (EPS)
-0.91
Revenue
9.06M
Net Profit
-16.22M

About Newron Pharmaceuticals Spa.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.newron.com
Headquarters
Milan, Lombardy, Ita
Founded
-
Newron Pharmaceuticals Spa. is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NP5. The last closing price for Newron Pharmaceuticals was 9.96 €. Over the last year, Newron Pharmaceuticals shares have traded in a share price range of 6.65 € to 13.50 €.

Newron Pharmaceuticals currently has 17,845,345 shares in issue. The market capitalisation of Newron Pharmaceuticals is 177.74 € million. Newron Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.30.

Ask ADVFN Intelligence (AI)

NP5 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.282.883625128739.7110.269.6375669.97791813DE
40.495.157894736849.510.5399999.0275019.82295921DE
121.6920.36144578318.313.57.2288239.18182874DE
261.8923.33333333338.113.57.2265458.87857581DE
521.9424.0993788828.0513.56.6580089.0204305DE
1568.634636.7256637171.35613.51.1364887.43984618DE
2603.7961.12903225816.213.51.1346116.77063386DE

NP5 - Frequently Asked Questions (FAQ)

What is the current Newron Pharmaceuticals share price?
The current share price of Newron Pharmaceuticals is 9.99 €
How many Newron Pharmaceuticals shares are in issue?
Newron Pharmaceuticals has 17,845,345 shares in issue
What is the market cap of Newron Pharmaceuticals?
The market capitalisation of Newron Pharmaceuticals is EUR 177.74M
What is the 1 year trading range for Newron Pharmaceuticals share price?
Newron Pharmaceuticals has traded in the range of 6.65 € to 13.50 € during the past year
What is the PE ratio of Newron Pharmaceuticals?
The price to earnings ratio of Newron Pharmaceuticals is -10.3
What is the cash to sales ratio of Newron Pharmaceuticals?
The cash to sales ratio of Newron Pharmaceuticals is 18.44
What is the reporting currency for Newron Pharmaceuticals?
Newron Pharmaceuticals reports financial results in EUR
What is the latest annual turnover for Newron Pharmaceuticals?
The latest annual turnover of Newron Pharmaceuticals is EUR 9.06M
What is the latest annual profit for Newron Pharmaceuticals?
The latest annual profit of Newron Pharmaceuticals is EUR -16.22M
What is the registered address of Newron Pharmaceuticals?
The registered address for Newron Pharmaceuticals is VIA ANTONIO MEUCCI 3, BRESSO, MILAN, LOMBARDY, 20091
What is the Newron Pharmaceuticals website address?
The website address for Newron Pharmaceuticals is www.newron.com
Which industry sector does Newron Pharmaceuticals operate in?
Newron Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
O0KBayridge Resources Corp
0.05 €
(29.87%)
2.5k
VOPInvestigator Resources Ltd
0.0175 €
(29.63%)
15.2k
W4VAlphaGen Intelligence Corp
0.011 €
(29.41%)
29.5k
G7PAEnergy Transition Minerals Ltd
0.0524 €
(27.18%)
75.25k
AA3Vortex Energy Corp
0.0368 €
(22.26%)
4.4k
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
312
L7C2Windfall Geotek Inc
0.0055 €
(-35.29%)
637
A7VAiMetal Resources Inc
0.121 €
(-27.54%)
30
CB82Gratomic Inc
0.0218 €
(-23.24%)
500
42FBAIML Innovations Inc
0.0484 €
(-21.68%)
61
RAEChina Rare Earth Holdings Ltd.
0.05 €
(12.11%)
273.98k
IFXInfineon Technologies AG
33.78 €
(8.08%)
245.11k
GRUGeely Automobile Holdings Ltd
1.9795 €
(7.46%)
221.15k
PTXPalantir Technologies Inc
96.51 €
(18.34%)
165.25k
4IPParkway Corporate Ltd
0.0066 €
(3.13%)
120k

Discussion

View Full Feed
doccjc doccjc 10 minutes ago
Great,,, I had sent a message on X,,, glad they fixed it,,
I can't get over the 80% reduction in tumor size and metastatic activity in 30 days !
RDGL
bbotcs bbotcs 12 minutes ago
mankind: Greenland 51st State, not Canada!
dinogreeves dinogreeves 12 minutes ago
Market is reversing into positive territory, reversing 80 point loss on Nasdaq, must be something cooking with these two super powers.
SMCI
bbotcs bbotcs 14 minutes ago
Gmenfan: Well the victims of the procedures will be able to sue her down the road.
nowwhat2 nowwhat2 15 minutes ago
When did he post that ?.......

https://investorshub.advfn.com/uimage/uploads/2025/2/4/dkzyqeth_@_3_duo_11pm_trump_said_buy_when.jpg


Answer - YUP !



Guy shouldn't even be ALLOWED to run around posting chit like that !

ETHUSD
bbotcs bbotcs 15 minutes ago
lj: I think Trump is looking at a U.S.-Canadian merger. Canada is a political Disneyland. This would be a good time for Quebec to go indy.
bbotcs bbotcs 17 minutes ago
lj: I think it was cancelled for this area. Film at 11.
mikepgator mikepgator 19 minutes ago
Nevermind, I emailed and got confirmation that it has been fixed.
RDGL
quester614 quester614 19 minutes ago
WRONG AGAIN. The consolidated statements of operations, also known as the income statement ARE found in the AUDITED FINANCIALS. So what's your point. That's not where your posted statement came from. TRY AGAIN post link and page #. LOLOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/2/4/qny
XERI
mikepgator mikepgator 25 minutes ago
Unless I’m not reading it correctly, it seems like there is a word missing here, if anyone has contact with someone at the company to fix it before the PR goes out.

“remained at the point of injection and no adverse ??? reported by any of the initial five patients since the initial tr
RDGL
Nrdc92 Nrdc92 27 minutes ago
Chs, I would argue that pps resiliency is solely down to limited float and LWLG's inclusion in the Russell 3000. Not due to any belief by anyone in the promise of LWLG. If any of those two factors breakdown - e.g., LWLG booted from the Russell in June, something that's highly likely IMO - this dog g
LWLG
robinandthe7hoods robinandthe7hoods 27 minutes ago
People have to remember that Verses AI isn't even out of beta yet.
Meanwhile,Open AI and every other LLM is on version 3-4-5.
LLMs are also made for the average joe because they are search engines.
Genius is an operating system that will mainly be used by compani
VRSSF
spdpro spdpro 28 minutes ago
Just to add >
That video of TTM is on TradingView platform
On Tos the TTM source code is Locked as it is a John Carter Licensed item > I forgot that
dinogreeves dinogreeves 28 minutes ago
Look at the earnings, this is just too ridiculous and look at where SMCI is seating at, SMCI makes 10 times more and yet because of no 10K and 10Q's is being punished by the market. Justified? Yes, but when those numbers and audit is released and they are not altered, SMCI will run.

SMCI
doccjc doccjc 29 minutes ago
They have the results from the 5,,, expanding from 30 to 50,,, I'd say thats a lot of results for the FDA, An 80% reduction in tumor size and metastatic activity in 1 patient after 30 days! That's huge!,,,, Talk about efficacy.
RDGL
BDEZ BDEZ 31 minutes ago
Trump's Crypto Czar, David Sacks, to host press conference tomorrow on securing America's leadership in the Digital Asset ecosystem.
BDEZ BDEZ 31 minutes ago
Trump's Crypto Czar, David Sacks, to host press conference tomorrow on securing America's leadership in the Digital Asset ecosystem.
dinogreeves dinogreeves 33 minutes ago
China just retaliated with imposing Tariffs on US Coal and Natural Gas. Futures are red, definitely not as bad as yesterday and it will work itself out.
SMCI
mikepgator mikepgator 35 minutes ago
Sounds like it can happen at any time:

“Additionally, as results emerge, they will be shared with the FDA to further support RadioGel®’s safety profile and reinforce our Investigational Device Exemption (IDE) submission and advance expanded indications for use in the United States.”
RDGL
janice shell janice shell 39 minutes ago
This is interesting:

https://bsky.app/profile/johnfugelsang.bsky.social/post/3lhcl5kbiyc2h
skitahoe skitahoe 40 minutes ago
I think the moderators should sticky this post, or the Law Review document within it.

A great deal of what's happened to NWBO has been exposed in detail by this and the Bamboo lounge article. Hopefully this is the precursor to the actual legal action occurring, and the UK regulators
NWBO
Squirrely_McShitty Squirrely_McShitty 40 minutes ago
Asked & answered on Borgers. They were the auditors in mid-June '23, and likely for the Form 10. Seeing the print rang a bell.

I've said my piece enough times. Come August, it trades or it don't. Can't say I don't care or that I believe there is some hidden powerhouse awaiting, but I
CNNA
StockItOut StockItOut 42 minutes ago
Anything just to argue, eh? WRONG question to ask your AI... again.

Did you even look up the 10-K? You lazy argumentative faker!

Maybe the CONSOLIDATED STATEMENTS OF OPERATIONS are not the audited part of the audited part of the 10-K.

Or, maybe they are.
XERI
mikepgator mikepgator 43 minutes ago
Press Release February 4, 2025 Vivos Inc. Reports Encouraging Human Clinical Trial Results and
Announces Expansion Plans
Statement from Vivos CEO, Dr. Michael Korenko (Richland, WA - February 4, 2025) - Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstr
RDGL

Your Recent History

TG
NP5
Newron Pharmaceuticals
BIT
UB51NB
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads